Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Memory Industry Cycle Raises Caution Amid AIDriven Rally Investor Warns Reddit Shares Decline After Meta Launches Forum App Intensifying Competition in Online Communities Analyst Review Viatris Inc Shows Potential Amid Generic Drug Market Shifts PlayStation Plus Price Hikes Draw Criticism From Subscribers Amid Growing Gaming Subscription Costs Iran Strikes Test Market Optimism Despite NearDeal Signals ArcBest Q1 2026 Earnings EPS Surpasses Estimates on Strong Cost Control WST Q1 2026 Earnings EPS Surges Past Estimates Stock Moves Marginally Higher CIT Inc Q1 2026 Earnings EPS Misses Estimates Amid Market Caution FCX Q1 2026 Earnings Strong EPS Beat Drives Positive Market Reaction GLMD Q4 2025 Earnings EPS Misses Estimates Amid Development Stage Uncertainty JBT Marel Corporation JBTM Gains 19 as Stock Tests Key Resistance at 141 Travere Therapeutics TVTX Hovers Near Resistance as Slight Dip Tests Support Levels Liberty Latin America LILA Slides 3 as Macro Headwinds Weigh on Telecom Sector CMS Energy Preferred CMSA Holds Steady at 2165 as Yield Attracts Income Seekers Sebi Chief Tuhin Kanta Pandey Backs Bond ETFs and Tokenisation as Corporate Debt Fundraising Crosses Rs 9 Lakh Crore Milestone Bitcoin Surges Past 77000 on Iran Deal Optimism and Nasdaq Crypto Options Development US Stock Market Rally Dow Jones and Nasdaq Rise Up to 07 as Chip Stocks Surge Micron Jumps 9 Understanding Bad Credit Personal Loans Key Features and Borrowing Considerations Oracle Corporation Expands Clinical Research with AI Integration Micron Breaches 1 Trillion Market Cap Milestone as AIDriven Memory Shortage Lifts Stock 19 Reddit Shares Decline After Meta Launches Forum App Intensifying Competition in Online Communities Dow Jones Hits Record High as Middle East Hopes Lift Wall Street Sentiment Sandisk CTO AI Race Shifts Focus from Compute to Memory Regeneron REGN and Parabilis Medicines Forge 232 Billion Deal to Tackle Undruggable Protein Targets